[1]
Sewda, D. et al. 2023. A double-blind, placebo-controlled, randomized clinical trial to evaluate the efficacy and safety of Virulina® along with standard treatment as per hospital protocol for the treatment of novel coronavirus (COVID-19). Journal of Drug Delivery and Therapeutics. 13, 9 (Sep. 2023), 91–97. DOI:https://doi.org/10.22270/jddt.v13i9.6210.